Cat.#: ACPP-1294
| Despition | DCC Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1816 | Human TRH Protein (AC1816) | 2 µg | inquiry |
| ACPP-1162 | Recombinant Human GDNF Protein (Fc Tag) (AC1162) | 50 µg | inquiry |
| ACPP-1156 | Recombinant Human GnRHR Protein (Fc Tag) (AC1156) | 50 µg | inquiry |
| ACPP-1792 | Rat CALB1 Protein (AC1792) | 1 µg | inquiry |
| ACPP-1734 | Human EFNA3 Protein (AC1734) | 5 µg | inquiry |
| ACPP-1210 | Alpha SNAP Blocking Peptide (AC1210) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.